Article Versions Notes

Chen J, Li S, Wang Q, Wang C, Qiu Y, Yang L, Han R, Du Q, Chen L, Dong Y, et al. Optimizing Antimicrobial Dosing for Critically Ill Patients with MRSA Infections: A New Paradigm for Improving Efficacy during Continuous Renal Replacement Therapy. Pharmaceutics. 2022; 14(4):842. https://doi.org/10.3390/pharmaceutics14040842

Chen, Jiaojiao, Sihan Li, Quanfang Wang, Chuhui Wang, Yulan Qiu, Luting Yang, Ruiying Han, Qian Du, Lei Chen, Yalin Dong, and et al. 2022. "Optimizing Antimicrobial Dosing for Critically Ill Patients with MRSA Infections: A New Paradigm for Improving Efficacy during Continuous Renal Replacement Therapy" Pharmaceutics 14, no. 4: 842. https://doi.org/10.3390/pharmaceutics14040842

Chen, J., Li, S., Wang, Q., Wang, C., Qiu, Y., Yang, L., Han, R., Du, Q., Chen, L., Dong, Y., & Wang, T. (2022). Optimizing Antimicrobial Dosing for Critically Ill Patients with MRSA Infections: A New Paradigm for Improving Efficacy during Continuous Renal Replacement Therapy. Pharmaceutics, 14(4), 842. https://doi.org/10.3390/pharmaceutics14040842